KTTA
Pasithea Therapeutics Corp

5,274
Mkt Cap
$16.4M
Volume
39,633.00
52W High
$3.79
52W Low
$0.281
PE Ratio
-0.14
KTTA Fundamentals
Price
$0.7101
Prev Close
$0.70
Open
$0.7108
50D MA
$0.9864
Beta
0.00
Avg. Volume
205,253.40
EPS (Annual)
-$12.69
P/B
0.43
Rev/Employee
$0.00
$3.47
Loading...
Loading...
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4

Frequently Asked Questions

What is Market Cap of Pasithea Therapeutics Corp?
What is the 52-week high for Pasithea Therapeutics Corp?
What is the 52-week low for Pasithea Therapeutics Corp?
What is Pasithea Therapeutics Corp stock price today?
What was Pasithea Therapeutics Corp stock price yesterday?
What is the PE ratio of Pasithea Therapeutics Corp?
What is the Price-to-Book ratio of Pasithea Therapeutics Corp?
What is the 50-day moving average of Pasithea Therapeutics Corp?
How many employees does Pasithea Therapeutics Corp have?

Latest KTTA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.